U.S. Hemp Roundtable Urges Congressional Action In Response To FDA’S Misguided Promotion Of Incomplete CBD Safety Data
General Counsel Jonathan Miller Raises Concerns Regarding FDA’s Stance on CBD Regulation WASHINGTON D.C. — On the heels of last week’s U.S. Food and Drug Administration (FDA) webinar for hemp …